Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.
[Diagnosis of multiple sclerosis].
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
MRI pattern in asymptomatic natalizumab-associated PML.
Features of anti-aquaporin 4 antibody-seronegative Thai patients with neuromyelitis optica spectrum disorders: A comparison with seropositive cases.
I-BET151 selectively regulates IL-6 production.
Conditional Ablation of Astroglial CCL2 Suppresses CNS Accumulation of M1 Macrophages and Preserves Axons in Mice with MOG Peptide EAE.
Safety and efficacy of reduced fingolimod dosage treatment.
Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study.
Antibodies as Mediators of Brain Pathology.
Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.
Large-scale production of human mesenchymal stem cells for clinical applications.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Bone loss with multiple sclerosis: effect of glucocorticoid use and functional status.
Regulatory T-Cells in Chronic Lymphocytic Leukemia and Autoimmune Diseases.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.
Treatment of mood disorders in multiple sclerosis.
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain.
High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Pages
« first
‹ previous
…
446
447
448
449
450
451
452
453
454
…
next ›
last »